To evaluate GBM’s response to TMZ, we performed in vitro TMZ cytotoxicity assays in short-term (6 days) cultured patient-derived GSCs (n = 69, main cohort) obtained from surgically resected IDH-wt primary GBM specimens. Here, IDH1 is linked to glioblastoma.